First Word Pharma: Press Release Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model Posted on December 27, 2024 at 10:25 am.Shared by contributor Noboru Hiroi, PhD, professor, Department of Pharmacology, was quoted in this article. Read More Link to UT Health San Antonio Newsroom story: Early Bumetanide restores social communication in fragile X, autism model Share This Article!